搜索临床试验以:Iodine-131
总计1189个结果
-
Motus Therapeutics, Inc.完全的
-
Swiss Federal Institute of TechnologyAlmazov National Medical Research Centre; University of Papua New Guinea完全的
-
Molecular Insight Pharmaceuticals, Inc.完全的
-
Cellectar Biosciences, Inc.完全的
-
Children's Hospital of PhiladelphiaFriedreich's Ataxia Research Alliance; Stealth BioTherapeutics Inc.主动,不招人
-
Stealth BioTherapeutics Inc.终止
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)终止既往骨髓增生异常综合征引起的急性髓性白血病 | 慢性粒单核细胞白血病 | 先前治疗过的骨髓增生异常综合征 | 缓解期成人急性髓性白血病 | 缓解期成人急性淋巴细胞白血病 | 难治性贫血伴原始细胞过多 | 难治性环状铁粒幼细胞性贫血 | 难治性血细胞减少伴多系发育不良 | 难治性血细胞减少伴多系发育不良和环状铁粒幼细胞 | 存在 CD45 阳性肿瘤细胞美国
-
University of WuerzburgDeutsche Krebshilfe e.V., Bonn (Germany)招聘中
-
Stealth BioTherapeutics Inc.完全的
-
National Cancer Institute (NCI)主动,不招人复发性甲状腺癌 | 难治性甲状腺癌 | III 期甲状腺滤泡性癌 AJCC v7 | IV 期甲状腺滤泡性癌 AJCC v7 | IV 期甲状腺乳头状癌 AJCC v7 | IVA 期甲状腺滤泡性癌 AJCC v7 | IVA 期甲状腺乳头状癌 AJCC v7 | IVB 期甲状腺滤泡性癌 AJCC v7 | IVB 期甲状腺乳头状癌 AJCC v7 | IVC 期甲状腺滤泡性癌 AJCC v7 | IVC 期甲状腺乳头状癌 AJCC v7 | 不可切除的甲状腺癌 | 分化型甲状腺癌 | III 期甲状腺髓样癌 AJCC v7 | IV 期甲状腺髓样癌 AJCC v7 | IVA 期甲状腺髓样癌 AJCC v7 | IVB 期甲状腺髓样癌 AJCC v7 | IVC 期甲状腺髓样癌... 及其他条件美国
-
Molecular Insight Pharmaceuticals, Inc.终止
-
Swiss Federal Institute of TechnologyNorth-West University, South Africa; Ministry of Health, Tanzania完全的
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterEli Lilly and Company招聘中
-
Wageningen UniversitySwiss National Science Foundation; Mahidol University; Nestlé Foundation; Unilever R&D; St. John's...完全的
-
Swiss Federal Institute of TechnologyNorth-West University, South Africa完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...GlaxoSmithKline完全的
-
Southwest Oncology GroupNational Cancer Institute (NCI)完全的
-
Stealth BioTherapeutics Inc.完全的
-
Weill Medical College of Cornell UniversityIsoRay Medical, Inc.撤销
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Swiss Federal Institute of TechnologyUniversity Hospital, Zürich; Swiss Federal Food Safety and Veterinary Office完全的
-
Peking University Third Hospital招聘中
-
Memorial Sloan Kettering Cancer CenterGT Medical Technologies, Inc.招聘中
-
Centre Hospitalier Sud Francilien完全的
-
Stealth BioTherapeutics Inc.完全的
-
Stealth BioTherapeutics Inc.终止
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)终止慢性粒单核细胞白血病 | 复发性成人急性髓性白血病 | 伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 伴有 Del(5q) 的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 继发性急性髓性白血病 | 儿童骨髓增生异常综合征 | 先前治疗过的骨髓增生异常综合征 | 复发性儿童急性髓性白血病 | 继发性骨髓增生异常综合征 | 成人急性髓性白血病伴 t(15;17)(q22;q12) | 难治性贫血伴原始细胞过多 | 难治性血细胞减少伴多系发育不良 | 转化中原始细胞过多的难治性贫血 | 环状铁粒幼细胞难治性贫血美国